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The measurement properties of the newly developed
Pediatric Quality of Life InventoryTM (PedsQLTM) 3.0
Transplant Module in pediatric solid organ transplant
recipients were evaluated. Participants included pedi-
atric recipients of liver, kidney, heart and small bowel
transplantation who were cared for at seven medical
centers across the United States and their parents.
Three hundred and thirty-eight parents of children ages
2–18 and 274 children ages 5–18 completed both the
PedsQLTM 4.0 Generic Core Scales and the Transplant
Module. Findings suggest that child self-report and
parent proxy-report scales on the Transplant Module
demonstrated excellent reliability (total scale score for
child self-report a = 0.93; total scale score for par-
ent proxy-report a = 0.94). Transplant-specific symp-
toms or problems were significantly correlated with
lower generic HRQOL, supporting construct validity.
Children with solid organ transplants and their parents
reported statistically significant lower generic HRQOL
than healthy children. Parent and child reports showed
moderate to good agreement across the scales. In
conclusion, the PedsQLTM Transplant Module demon-
strated excellent initial feasibility, reliability and con-
struct validity in pediatric patients with solid organ
transplants.
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Introduction
The World Health Organization (WHO) defines health as a
‘state of complete physical, mental, and social well-being,
and not merely the absence of disease or infirmity’ (1).
The growing literature in pediatric solid organ transplanta-
tion supports the WHO’s definition of health through an
increasing recognition of the interaction between physi-
ologic, developmental, and psychosocial factors in overall
patient outcomes. Assessment of a person’s health-related
quality of life (HRQOL) facilitates the evaluation of patient
outcomes by providing a more thorough understanding of
the child’s and family’s experience of solid organ transplant
and its treatment. HRQOL has been defined as an individ-
ual’s subjective experience of their illness, and the impact
that illness and its treatment have on the individual’s func-
tioning in a variety of domains (2–5). The key domains of
HRQOL include physical, psychological and social function-
ing (2,5) as well as the impact of illness on the ability to
engage in activities of daily living (2,4).
Although researchers have begun to recognize the impor-
tant role of HRQOL in evaluating the effectiveness of med-
ical treatments in pediatric chronic conditions, relatively
few studies have examined HRQOL in pediatric solid or-
gan transplant recipients. Transplantation often leads to
improved physical health. However, the impact of the med-
ications, hospitalizations, clinic visits and invasive proce-
dures, as well as the impact of living with the uncertainty
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of graft survival and long-term health status may all affect
an individual’s HRQOL. Therefore, assessing an individual’s
HRQOL after solid organ transplant can help evaluate the
relative efficacy of medical interventions (4) and facilitate
improvement in medical decision-making.
HRQOL has been assessed using both generic and
disease-specific measures. Generic measures allow for the
assessment of common dimensions among both healthy
and chronically ill children, and allow for comparisons
across populations (6–9). However, generic measures may
be insensitive to a number of important disease-specific
issues (2,10). Disease-specific measures assess specific
outcomes and allow for the assessment of clinically rele-
vant issues within a particular illness-group (11). Varni et al.
(5) propose a modular approach to HRQOL assessment
that includes both generic and illness-specific measures.
Pediatric measures of transplant-specific HRQOL must
be sensitive to developmental issues. Parent proxy-report
measures have been used to avoid the problems inherent
in obtaining pediatric patient self-report, but the accuracy
of only using parent proxy-report measures has been ques-
tioned (12–14). Since the validity, reliability and meaning-
fulness of children’s responses to any HRQOL measure
may fluctuate over time (5), measures of disease-specific
HRQOL in a pediatric population should include both child
and parent reports to measure their perspectives on pa-
tient HRQOL.
The lack of a valid and reliable transplant-specific HRQOL
measure has hampered our ability to identify children at
different levels of morbidity, determine the differential im-
pact of various treatment regimens, predict which patients
are at risk for emotional difficulties and/or poor regimen
adherence, and identify emerging problems for long-term
survivors. The development of such a transplant-specific
measure would provide a more thorough understanding
of the multidimensional nature of both the child’s experi-
ence and the parent’s perceptions of the child’s experience
regarding the impact of solid organ transplantation.
To address this critical, unmet need, this study investi-
gates the initial feasibility, reliability and validity of the Pedi-
atric Quality of Life InventoryTM (PedsQLTM) 3.0 Transplant
Module in a general population of children with solid or-
gan transplants. Once the measurement properties of this
newly developed measure are demonstrated in this diverse
population of solid organ transplant patients, further stud-
ies can assess the clinical utility of the measure within
organ specific transplant groups. For the present study,
aimed at assessing the initial feasibility, reliability and valid-
ity of the PedsQLTM 3.0 Transplant Module, the PedsQLTM
4.0 Generic Core Scales was also administered. We hy-
pothesized that the Generic Core Scales would distinguish
between healthy children and children with solid organ
transplants. We also hypothesized that greater transplant-
specific symptoms or difficulties would be associated with
lower generic HRQOL based on the impact of disease-
specific symptoms on generic HRQOL.
Materials and Methods
Solid organ transplant sample
Eight hundred seventy-four families were invited to participate from seven
sites across the United States. A total of 342 participants (274 children
ages 5–18 years and 338 parents of children ages 2–18 years) completed
the questionnaires, a response rate of 39%. The sample consisted of chil-
dren who had received the following types of solid organ transplants: 184
(53.8%) liver, 90 (26.3%) kidney, 33 (9.6%) heart, 6 (1.8%) small bowel,
and 27 (8.5%) multiple organs (heart and kidney = 2, liver and kidney = 2,
liver, kidney and small bowel = 2, liver and small bowel = 21). The mean
time since transplantation for the sample was 7.01 years (SD = 4.82;
Range = 0.24–18.37). The average age of the 185 boys (54.1%) and 152
girls (44.4%) was 11.3 years (SD = 5.0). With respect to race/ethnicity, the
sample contained 249 (72.8%) White non-Hispanic, 34 (9.9%) Hispanic, 30
(8.8%) Black non-Hispanic, 12 (3.5%) Asian/Pacific Islander and 17 (5.0%)
Other or Missing. With respect to parent education, 12% did not com-
plete high school, 18.8% had a high school degree, 29% completed some
college, 24.5% had a college degree and 14.3% had a graduate degree.
Family income showed 34% earning less than $50,000 per year, 38% earn-
ing between $51,000 and $100,000, 15% earning between $101,000 and
$150,000 and 10% earning more than $151,000 per year.
Healthy Children Sample: PedsQLTM Generic Core Scales
The healthy children sample (n = 2039) was derived from the previously
conducted PedsQLTM 4.0 initial field test (5) and a State’s Children’s Health
Insurance Program (SCHIP) evaluation in California (15). Children were as-
sessed either in physicians’ offices during well-child visits, by telephone, or
via a statewide mailing. The average age of the 1081 boys (53.0%) and 958
girls (47.0%) was 9.7 years (SD = 4.4; Missing = 3, 0.1%). With respect to
race/ethnicity, the sample contained 1311 (64.3%) White non-Hispanic, 271
(13.3%) Hispanic, 232 (11.4%) Black non-Hispanic, 142 (7.0%) Asian/Pacific
Islander and 83 (4.1%) Other ethnicities. Parental level of education was
unavailable for the total sample, although the statewide SCHIP sample was
representative of low-income families. The solid organ transplant sample
was randomly matched to the healthy children sample by age, gender and
race/ethnicity utilizing the SPSS Version 16.0 statistical software random
sample case selection command (16).
Measures
PedsQLTM 3.0 Transplant Module: The PedsQLTM 3.0 Transplant Mod-
ule was developed based on our research and clinical experiences with
organ transplantation and other chronic conditions, and the instrument de-
velopment literature (17–20). The Module Scales were developed through
focus groups, cognitive interviews, pretesting and field-testing protocols
(details contained in Appendix A). The child self-report items are listed in
Appendix B.
The 46-item PedsQLTM 3.0 Transplant Module encompasses 8 Scales: 1)
About My Medicines I (9 items; barriers to medical regimen adherence),
2) About My Medicines II (8 items; medication side effects), 3) My Trans-
plant and Others (8 items; social relationships and transplant), 4) Pain and
Hurt (3 items; physical discomfort), 5) Worry (7 items; worries related to
health status), 6) Treatment Anxiety (4 items; fears regarding medical pro-
cedures), 7) How I Look (3 items; impact of transplant on appearance),
and 8) Communication (4 items; communication with medical personnel
and others regarding transplant issues). The format, instructions, Likert re-
sponse scale, and scoring method for the PedsQLTM 3.0 Transplant Module
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are identical to the PedsQLTM 4.0 Generic Core Scales, with higher scores
indicating better HRQOL (5).
The Scales are comprised of parallel child self-report and parent proxy-report
formats for children ages 5–18 years, and a parent proxy-report format for
children ages 2–4 years. Child self-report forms are specific for ages 5–7,
8–12, and 13–18 years. Parent proxy-report forms are specific for children
ages 2–4 (toddler), 5–7 (young child), 8–12 (child), and 13–18 (adolescent),
and assess parents’ perceptions of their child’s HRQOL. The instructions
ask how much of a problem each item has been during the past one month.
A 5-point response scale is utilized across child self-report for ages 8–18
and parent proxy-report (0 = never a problem; 1 = almost never a problem;
2 = sometimes a problem; 3 = often a problem; 4 = almost always a
problem). To further increase the ease of use for the young child self-report
(ages 5–7), the response scale is reworded and simplified to a 3-point
scale (0 = not at all a problem; 2 = sometimes a problem; 4 = a lot of a
problem). This simplification to a 3-point scale for the young child self-report
is consistent with the PedsQLTM 4.0 Generic Core Scales as well as with
all of the PedsQL illness-specific modules.
Items are reverse-scored and linearly transformed to a 0–100 scale (0 = 100,
1 = 75, 2 = 50, 3 = 25, 4 = 0), so that higher scores indicate better
HRQOL. The Total Scale Score is computed as the sum of all the items
on the PedsQLTM 3.0 Transplant Module divided by the number of items
answered. Scale Scores are computed as the sum of the items divided by
the number of items answered (this accounts for missing data). If more than
50% of the items in the scale are missing, the Scale Score is not computed
(21). This accounts for the differences in sample sizes for scales reported in
the tables. Although there are other strategies for imputing missing values,
this computation is consistent with the previous PedsQLTM peer-reviewed
publications as well as other well-established HRQOL measures (5,22,23).
The PedsQLTM 4.0 Generic Core Scales: The 23-item PedsQLTM 4.0
Generic Core Scales encompass: 1) Physical Functioning (8 items), 2) Emo-
tional Functioning (5 items), 3) Social Functioning (5 items), and 4) School
Functioning (5 items) (5,14). To create the Psychosocial Health Summary
Score, the mean is computed as the sum of the items divided by the num-
ber of items answered in the Emotional, Social, and School Functioning
Scales.
The PedsQLTM Family Information Form: Parents completed the
PedsQLTM Family Information Form which contains demographic informa-
tion including the child’s date of birth, gender, race/ethnicity, and parental
education and occupation information (5).
Procedures: Participants were children ages 5–18 years who had received
a solid organ transplant and parents of children ages 2–18 years who had
received a solid organ transplant at 7 clinical centers across the United
States (Children’s Memorial Hospital, Chicago, n = 122; University of Al-
abama, Birmingham, n = 30; University of Michigan, Ann Arbor, n = 49;
Nebraska Medical Center, University of Nebraska, Omaha, n = 79; Texas
Children’s Hospital, Houston, n = 13; University of California, Los Angeles,
n = 32; Children’s Hospital of Wisconsin-Milwaukee, n = 17). The Children’s
Memorial Hospital site initially administered only the PedsQLTM 3.0 Trans-
plant Module (n = 93), and then with a sample that excluded the original 93
respondents, an additional 29 completed both the Transplant Module and
Generic Core Scales. The other 6 sites administered the Transplant Module
and Generic Core Scales at the same time. This explains the larger sample
size for the Transplant Module in the tables.
All eligible patients at each clinical site were invited to participate in the
study. Participants completed the PedsQLTM 3.0 Transplant Module either
during routinely scheduled clinic visits (n = 109) or via a mass mailing
(n = 233) of transplant recipients from each clinical site. All parents com-
pleted the PedsQLTM Family Information Form. The human subject institu-
tional review boards at each center approved the study.
Statistical analysis: Feasibility was determined from the percentage of
missing values (23). Cronbach’s coefficient alpha was utilized to determine
scale internal consistency reliability (24). Scales with reliabilities of 0.70 or
greater are recommended for comparing patient groups, while a reliability
criterion of 0.90 is recommended for analyzing individual patient scores
(25,26).
Construct validity for the Generic Core Scales was determined utilizing the
known-groups method (27). The known-groups method compares scale
scores across groups known to differ in the health construct being inves-
tigated. Generic Core Scales scores in groups differing in known health
condition (healthy children and children with a solid organ transplant) were
computed using independent samples t-tests. We hypothesized that the
Generic Core Scales would distinguish between healthy children and chil-
dren with solid organ transplants based on previous PedsQLTM findings in
other pediatric chronic conditions (28–30). Effect sizes were calculated to
determine the magnitude of the differences (31). Effect size as utilized in
these analyses was calculated by taking the difference between the healthy
sample mean and the organ transplant sample mean, divided by the pooled
standard deviation. Effect sizes for differences in means are designated as
small (.20), medium (.50), and large (.80) in magnitude (18).
An analysis of the intercorrelations among the Generic Core Scales and
Summary Scores with the Transplant Module Scale Scores was used to ex-
amine construct validity for the Transplant Module. Computing the intercor-
relations among scales provides initial information on the construct validity
of an instrument (26). We hypothesized greater disease-specific symptoms
or problems would correlate with lower overall generic HRQOL based on
the conceptualization of disease-specific symptoms as causal indicators of
generic HRQOL (32). Pearson Product Moment Correlation coefficients are
designated as small (.10–.29), medium (.30–.49), and large (≥.50) (31).
A principal components factor analysis of the PedsQLTM 3.0 Transplant
Module extracting eight factors and one factor was also conducted. Item
loadings were assessed to determine if each subscale loaded onto a distinct
factor or if a total Transplant Module score best represented the data. A
cut-off value of 0.30 was utilized.
Intraclass Correlation Coefficients (ICCs) were used to determine agree-
ment between child self-report and parent proxy-report (33). The ICC pro-
vides an index of absolute agreement as it takes into account the ratio be-
tween subject variability and total variability (33,34). ICCs are designated as
≤0.40 poor to fair agreement, 0.41–0.60 moderate agreement, 0.61–0.80
good agreement, and 0.81–1.00 excellent agreement (35,36). Statistical
analyses were conducted using SPSS Version 16.0 for Windows (16).
Results
Feasibility: missing item responses
The percentage of missing item responses was 2.1%
and 0.8%, respectively, for all scales for child self-report
and parent proxy-report on the PedsQLTM 3.0 Transplant
Module. For child self-report and parent proxy-report on
the PedsQLTM 4.0 Generic Core Scales, the percentage
of missing item responses was 1.7% and 0.4%, respec-
tively, for all scales except the parent proxy-report School
Functioning Scale. The percentage of missing items for
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Table 1: PedsQLTM 4.0 Generic Core Scales scores and reliability for child self-report and parent proxy-report for solid organ transplant
sample and comparisons with matched healthy children scores
Solid Organ Transplant Healthy
Number Effect
Scale of Items n a Mean ± SD N Mean ± SD Difference Size
Child self-report
Total Score 23 199 0.91 76.09 ± 17.25 1302 85.66 ± 11.99 9.57∗ 0.75
Physical Health 8 199 0.85 81.06 ± 19.67 1299 89.53 ± 12.38 8.47∗ 0.62
Psychosocial Health 15 198 0.87 73.73 ± 17.22 1298 83.64 ± 13.60 9.91∗ 0.70
Emotional Functioning 5 198 0.79 73.90 ± 21.04 1302 81.50 ± 17.52 7.60∗ 0.42
Social Functioning 5 198 0.79 80.22 ± 20.65 1296 87.15 ± 15.77 6.93∗ 0.42
School Functioning 5 196 0.76 66.56 ± 21.95 1279 82.23 ± 16.29 15.67∗ 0.91
Parent proxy-report
Total Score 23 247 0.94 74.93 ± 19.40 2017 85.41 ± 13.49 10.48∗ 0.74
Physical Health 8 247 0.91 79.10 ± 23.25 2017 88.26 ± 16.69 9.16∗ 0.52
Psychosocial Health 15 247 0.91 72.68 ± 19.53 2019 83.79 ± 13.94 11.11∗ 0.76
Emotional Functioning 5 247 0.84 74.13 ± 21.28 2017 82.24 ± 16.16 8.11∗ 0.48
Social Functioning 5 247 0.87 76.48 ± 23.80 2017 87.32 ± 16.68 10.84∗ 0.62
School Functioning 5 228 0.81 65.93 ± 24.86 1829 81.27 ± 17.96 15.34∗ 0.81
∗p < 0.001 based on independent samples t-tests. Higher values equal better health-related quality of life. Effect sizes designated as
small (0.20), medium (0.50) and large (0.80). a, Cronbach’s coefficient alpha; SD, standard deviation.
the proxy-report School Functioning Scale was 0.8% (ages
5–18) and 42.9% (ages 2–4). This large percentage for
toddlers (ages 2–4) may exist since instructions on the
PedsQLTM toddler form ask parents to complete the School
Functioning Scale if their child attends school or daycare
and many toddlers do not attend school or daycare.
Internal consistency reliability
Table 1 presents internal consistency reliability coefficients
for the Generic Core Scales. All child self-report and parent
proxy-report scales on the Generic Core exceed the min-
imum reliability standard of 0.70 required for group com-
parisons. The Total Scale Scores for both child self-report
and parent proxy-report exceeds the reliability criterion of
0.90 recommended for analyzing individual patient scores.
Internal consistency reliability coefficients for the Trans-
plant Module are shown in Table 2. All child self-report and
parent proxy-report scales on the Transplant Module ex-
ceed the minimum reliability standard of 0.70 required for
group comparisons. The Total Scale Scores for both child
self-report and parent proxy-report for the Transplant Mod-
ule exceed the reliability criterion of 0.90 recommended
for analyzing individual patient scores.
Construct validity
Table 1 presents the differences between healthy children
and children with solid organ transplants. For each Generic
Core Scale and Summary Score, children with solid organ
transplants and their parents report statistically significant
lower HRQOL than healthy children. The majority of effect
sizes are in the medium range, supporting discriminant
validity. The largest effect sizes are demonstrated on the
School Functioning Scale for both child self-report (0.91)
and parent proxy-report (0.81).
Table 3 presents the intercorrelations between the Generic
Core Scales and summary scores with the Transplant Mod-
ule. The majority of intercorrelations are in the medium to
large range, supporting construct validity of the Transplant
Module.
Factor analysis
A principal components factor analysis of the PedsQLTM
3.0 Transplant Module extracting eight factors and one
factor revealed a one-factor solution best represented the
data. While for the one-factor solution two of the items for
child self-report and one item for parent proxy-report did
not meet the 0.30 cut-off value, these items were retained
given that the items were generated by focus groups and
cognitive interviews of pediatric patients who had under-
gone solid organ transplantation and their parents and thus
we felt these items were of clinical importance since they
were identified by children and parents as being so. Based
on these findings, a Total Transplant Module score was
included in the analyses.
Parent/child agreement
ICCs between child and parent report are shown in Table 4.
All of the ICCs are in the moderate to good agreement
range for the PedsQLTM Scales. The greatest overall agree-
ment is found on Total Generic Core Scale Score (0.71),
School Functioning Scale (0.71), and About Medicines II
Scale (0.71).
Discussion
The present study provides initial support for the feasibil-
ity, reliability and validity of the PedsQLTM 3.0 Transplant
Module in a general population of children with solid organ
transplants. Moreover, it provides support for the psycho-
metric utility of the PedsQLTM 4.0 Generic Core Scales
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Table 2: PedsQLTM 3.0 Transplant Module scores and reliability for child self-report and parent proxy-report
Number
Scale of Items n a Mean ± SD
Child self-report
Total Score 46 269 0.93 79.03 ± 14.36
About My Medicines I 9 272 0.77 83.08 ± 14.98
About My Medicines II 8 270 0.74 86.58 ± 16.19
My Transplant and Others 8 269 0.78 74.03 ± 19.77
Pain and Hurt 3 269 0.72 71.10 ± 23.43
Worry 7 268 0.88 79.44 ± 21.81
Treatment Anxiety 4 269 0.84 74.77 ± 27.23
How I Look 3 268 0.77 76.26 ± 26.76
Communication 4 268 0.80 76.84 ± 23.45
Parent proxy-report
Total Score 46 338 0.94 79.43 ± 14.88
About His/Her Medicines I 9 336 0.84 84.77 ± 16.04
About His/Her Medicines II 8 336 0.77 83.74 ± 17.66
Transplant and Others 8 338 0.85 76.90 ± 19.78
Pain and Hurt 3 337 0.71 75.62 ± 20.99
Worry 7 337 0.91 78.05 ± 23.30
Treatment Anxiety 4 338 0.88 71.61 ± 27.45
Perceived Physical Appearance 3 337 0.80 78.76 ± 24.42
Communication 4 337 0.92 77.60 ± 26.61
Higher values equal better health-related quality of life. a, Cronbach’s coefficient alpha; SD, standard deviation.
in children who have received a solid organ transplant.
Both the Generic Core and the Transplant Module showed
minimal missing values, supporting feasibility of the mea-
sures. Internal consistency for the Transplant Module Total
Score exceeded the 0.90 criterion, and the factor analysis
supported the use of a total score as a summary score
for the primary analysis of HRQOL in children with solid
organ transplants. The Transplant Module scale scores
showed alpha coefficients ranging from 0.76 to 0.91, sug-
gesting that each subscale can be used to examine specific
Table 3: Pearson’s product moment correlations among PedsQLTM scales for child self-report (above diagonal) and parent proxy-report
(below diagonal) for solid organ transplant sample
T PH Psy EF SF Sch TS AI AII TO P W TA PA C
PedsQLTM Generic Core Scales
Total Generic Core (T) – 0.88 0.96 0.78 0.81 0.78 0.65 0.52 0.45 0.48 0.53 0.47 0.45 0.32 0.50
Physical Health (PH) 0.89 – 0.70 0.57 0.61 0.56 0.54 0.46 0.47 0.37 0.47 0.37 0.34 0.22a 0.37
Psychosocial Health (Psy) 0.95 0.71 – 0.81 0.84 0.81 0.68 0.53 0.40 0.53 0.51 0.52 0.45 0.38 0.52
Emotional Functioning (EF) 0.76 0.53 0.83 – 0.55 0.45 0.55 0.42 0.35 0.39 0.47 0.44 0.39 0.29 0.44
Social Functioning (SF) 0.86 0.69 0.86 0.57 – 0.52 0.61 0.48 0.31 0.52 0.34 0.48 0.39 0.34 0.51
School Functioning (Sch) 0.81 0.61 0.85 0.56 0.61 – 0.50 0.38 0.34 0.38 0.45 0.34 0.35 0.27 0.34
PedsQLTM Transplant Module
Total Score (TS) 0.73 0.63 0.71 0.63 0.64 0.55 – 0.74 0.63 0.82 0.54 0.82 0.62 0.71 0.66
About Medicines I (AI) 0.57 0.51 0.53 0.50 0.45 0.43 0.71 – 0.44 0.58 0.40 0.49 0.32 0.42 0.44
About Medicines II (AII) 0.58 0.53 0.54 0.49 0.46 0.43 0.71 0.43 – 0.48 0.37 0.47 0.25 0.41 0.27
Transplant and Others (TO) 0.68 0.54 0.69 0.58 0.68 0.50 0.85 0.59 0.49 – 0.36 0.60 0.33 0.62 0.50
Pain and Hurt (P) 0.61 0.55 0.57 0.53 0.40 0.53 0.59 0.50 0.43 0.43 – 0.38 0.20a 0.30 0.22a
Worry (W) 0.46 0.41 0.43 0.40 0.39 0.32 0.77 0.43 0.47 0.54 0.37 – 0.44 0.59 0.46
Treatment Anxiety (TA) 0.40 0.36 0.38 0.33 0.37 0.30 0.60 0.26 0.29 0.45 0.24 0.47 – 0.38 0.50
Perceived Physical 0.48 0.39 0.49 0.48 0.43 0.33 0.70 0.40 0.43 0.61 0.42 0.50 0.32 – 0.42
Appearance (PA)
Communication (C) 0.50 0.38 0.52 0.42 0.51 0.42 0.63 0.28 0.36 0.57 0.23 0.34 0.37 0.42 –
All values are statistically significant at p < 0.001 except for superscript ‘a’ which is statistically significant at p < 0.01.
Pearson’s product moment correlations for child self-report are presented above the diagonal, parent proxy-report are presented below.
Pearson’s product moment correlations are designated as small (0.10), medium (0.30) and large (0.50).
T = Total Generic Core; PH = Physical Health; Psy = Psychosocial Health; EF = Emotional Functioning; SF = Social Functioning; Sch =
School Functioning; TS = Total Score; AI = About Medicines I; AII = About Medicines II; TO = Transplant and Others; P = Pain and Hurt;
W = Worry; TA = Treatment Anxiety; PA = Perceived Physical Appearance; C = Communication.
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Table 4: Intraclass correlations (ICC) between child self-report and
parent proxy-report on the PedsQLTM 4.0 Generic Core Scales and
the PedsQLTM 3.0 Transplant Module
Parent-Child
Scale Agreement ICC
PedsQLTM Generic Core Scales








About Medicines I 0.67∗
About Medicines II 0.71∗
Transplant and Others 0.62∗
Pain and Hurt 0.60∗
Worry 0.52∗
Treatment Anxiety 0.59∗
Perceived Physical Appearance 0.52∗
Communication 0.43∗
∗p < .001. ICCs are designated as ≤0.40 poor to fair agreement,
0.41–0.60 moderate agreement, 0.61–0.80 good agreement and
0.81–1.00 excellent agreement.
ICC = Intraclass correlation.
domains of transplant-specific HRQOL as well as using the
total score for an overall assessment of transplant-specific
HRQOL.
Consistent with our hypotheses, the Generic Core Scales
differentiated HRQOL between children receiving a solid
organ transplant and children who are healthy. Children
with solid organ transplants reported lower HRQOL than
did healthy children, with school functioning showing the
greatest differences between healthy and transplanted
children. The differences in reports regarding school func-
tioning may be a result of neurocognitive issues related
to the child’s transplant procedure, current medical condi-
tion, and/or medication regimen. Alternatively, differences
in school function may also be related to missing days of
school for clinic or lab visits, hospitalizations, or intercurrent
illnesses. The difficulties in school functioning reported by
transplant recipients suggest that clinicians should attend
to the child’s academic functioning and should encourage
families to advocate for their child’s academic support.
Children with solid organ transplants showed moderate
to good agreement with their parent’s scores, with the
strongest agreement in the area of medication side-
effects. This finding suggests that both parents and their
children are keenly aware of the negative impact of med-
ication side effects. Studies suggested that side effects
may be a key factor in medication nonadherence (37), so
careful attention to concerns about medication side effects
during clinic visits is warranted.
The present study has several strengths, including the rig-
orous methods used to construct the measure, the large
sample size, the broad age-range of participants, the diver-
sity of the population (73% Caucasian), the nation-wide
representation of the participants (7 clinical sites from
across the country), and the assessment of recipients of
four different transplanted organs.
Limitations include the lack of information on families who
chose not to participate in the study, which may limit the
generalizability of the findings. While our response rate
was expected for the mode and method of survey admin-
istration utilized (one-time only mailing) (38), it may limit the
generalizability of our findings. In addition, a high propor-
tion of the parents in the present sample had at least some
postsecondary education, which may not be representa-
tive of the general adult population in the US, and may fur-
ther limit the generalizability of these findings. Feasibility
in the present study was assessed solely by the percent-
age of missing values; future investigations should also
evaluate the feasibility of these measures with regard to
completion time and nonresponse rate. In addition, we did
not collect test-retest reliability data. However, test-retest
reliability may not be as useful in determining reliability of
the Transplant Module as measuring internal consistency
reliability, since fluctuations in the children’s health status
may influence their HRQOL. The only measure used to
assess construct validity was the PedsQLTM Generic Core
Scales. Other measures assessing such constructs as de-
pression, anxiety, family communication, and adherence
to medical regimens were not collected for this study (to
reduce participant burden), and future comparisons among
these measures may add important information regarding
the construct validity of the Transplant Module.
Testing of the PedsQLTM Transplant Module with larger
organ-specific populations is a necessary step in the it-
erative validation process for this new measure. In order
to assess the clinical utility of this newly developed mea-
sure, these future studies should also assess the similari-
ties and differences among the different solid organ trans-
plant groups. Such an analysis was beyond the scope this
study. Future studies should also assess such important
medical factors as graft-function, medications prescribed
(e.g. prednisone, tacrolimus, prograf), number of rejection
episodes, length of time since transplant, and hospitaliza-
tion days. Concurrently assessing important psychosocial
factors such as peer relationships, extracurricular activities
and emotional functioning will also add invaluable infor-
mation regarding the clinical utility of this measure. Such
clinically vital information, in conjunction with this newly
developed, psychometrically sound measure of transplant-
specific quality of life, will facilitate the development of
appropriate prevention and intervention programs. The de-
velopment of this new PedsQLTM 3.0 Transplant Module
should help clinicians identify children at different levels of
morbidity, identify the differential impact of various treat-
ment regimens, identify those children at risk for emotional
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difficulties, and identify emerging problems for long-term
survivors. Use of the measure in clinical trials could fa-
cilitate a more thorough understanding of the multidimen-
sional nature of both the child’s experience and the parent’s
perceptions of their child’s experiences regarding the im-
pact of solid organ transplantation on generic and disease-
specific HRQOL and facilitate medical decision-making.
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Appendix A
In Phase I of the instrument development for the PedsQLTM Trans-
plant Module, an item pool designed to address HRQOL issues
salient to pediatric transplant recipients and their families was cre-
ated. To generate relevant items, fourteen focus groups were con-
ducted. Participants in the focus groups included three separate
groups of health-care team members from the liver, kidney and
heart solid organ transplant teams at a large Midwestern pediatric
hospital (n = 30). Separate groups of the parents of heart, kidney
and liver transplant recipients (n = 32) and separate groups of chil-
dren and teenagers (ages 8–18) who had received heart, kidney
and liver transplants were also completed (n = 17).
Data collected from these focus groups were used to generate
the items for the initial measure. The 46-item measure generated
from the focus groups consisted of three versions: a young child
self-report (5–7 year olds), a child self-report (8–12 year olds) and
an adolescent report (13–18 year olds), with parallel parent proxy-
report versions covering ages 2–18 to facilitate a family-centered
approach to the assessment of HRQOL.
In Phase II, cognitive interviews were completed with 25 families
to obtain feedback about each item from this newly generated
measure. Feedback regarding the clarity of the wording, problems
with administration and interpretation of instructions were sought.
Nine families participated from the kidney transplant group, nine
from the liver transplant group, and seven from the heart trans-
plant group. Children’s ages ranged from 5 to 18 years of age.
Revisions of the measures were made based on the feedback
from the children and their parents.
In Phase III, the revised 46-item questionnaire was administered
to patients and their parents who were transplant recipients from
a large Midwestern pediatric hospital who did not participate in ei-
ther Phases I or II of the study. Ninety-one parents and 76 children
completed the questionnaires. The Cronbach Alphas for this initial
sample were good, ranging from.56-.86 for the child self-report
measures, and from 0.57 to 0.90 for the parent-proxy measures,
suggesting adequate internal consistency of the individual Trans-
plant Module scales. Preliminary factor analyses suggested that
most items performed well, with only four items showing low
communalities.
The final phase, reported in this manuscript, involved recruiting a
larger sample size from solid organ transplant recipients across
the country to insure an appropriately representative sample to
determine the feasibility, reliability, and validity of the PedsQLTM
3.0 Transplant Module.
Appendix B: PedsQLTM 3.0 Transplant
Module Child Self-Report Item Content
About My Medicines I
1. My medicines make me feel sick
2. My medicines make me feel grumpy
3. I forget to take my medicines
4. It is hard for me to take my medicines
5. It is hard for me to swallow my medicines
6. I don’t like the taste of my medicines
7. I don’t like having to take my medication all the time
8. It is hard for me to fit my medicines into my day
9. I get mad when I have to take my medications
About My Medicines II
1. My medicines make my stomach/tummy bigger
2. My medicines make my face look puffy
3. My medicines make my teeth look different
4. My medicines make me gain weight
5. My medicines make me hairy
6. My medicines make my gums big
7. My medicines keep me from growing tall
8. My medicines give me pimples
My Transplant and Others
1. Other people treat me differently because of my transplant
2. I feel different than other kids my age because I’ve had a
transplant
3. My parents don’t let me do activities I want to do because
of my transplant
4. Other people don’t seem to understand what I’ve been
through
5. I feel left out of things because of my transplant
6. It is hard for me to talk to other people about my transplant
7. My parents nag me about taking my medications
8. My doctors nag me about taking my medications
Pain and Hurt
1. I get stomachaches
2. I get headaches
3. I get backaches
Worry
1. I worry about side effects from medicines
2. I worry about whether or not my medicines are working
3. I worry that something is wrong when I don’t feel well
4. I worry that my doctor will find something wrong with me
5. I worry about whether or not my transplant is working
6. I worry that I will have to have another transplant
7. I worry that I won’t be able to do the things I used to
because of my transplant
Treatment Anxiety
1. I get scared when I have to go to the doctor
2. I get scared when I have to go to the hospital
3. I get scared about having needle sticks (i.e. injections,
blood tests, IV’s)
4. I get scared when I have to have medical procedures (i.e.
biopsy)
How I Look
1. I don’t like other people to see my scars
2. I worry that my medicines will change the way I look
3. I am embarrassed when other people see my body
Continued.
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Communication
1. It is hard for me to tell the doctors and nurses how I feel
2. It is hard for me to ask the doctors and nurses questions
3. It is hard for me to explain my transplant to other people
4. It is hard for me to understand what the doctors and nurses
are telling me
Reproduced with permission from J. W. Varni, PhD Copyright C©
1998.
The PedsQLTM is available at http://www.pedsql.org.
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